Workflow
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
Accessnewswire·2025-11-12 15:00

Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populations FDA clearance of IND application triggered a US5mmilestonepaymenttoEvotecHAMBURG,DE/ACCESSNewswire/November12,2025/EvotecSE(FrankfurtStockExchange:EVT,SDAX/TecDAX,PrimeStandard,ISIN:DE0005664809,WKN566480;NASDAQ:EVO)todayannouncedthatithasreceivedaUS 5 m milestone payment to Evotec HAMBURG, DE / ACCESS Newswire / November 12, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that it has received a US 5 m milestone payment from Bristol Myers Squibb, following the acceptance of an Investigational ...